U.S. Patent
BIO 2017
National Cancer Conference
Cancer Research News- American Cancer Society Launches Return to Screening Initiative with Support from Genentech February 25, 2021Nationwide Effort Aims to Increase Breast, Cervical, Colorectal, and Lung Cancer Screening Rates
- Don't Let the COVID-19 Pandemic Stall Your Colorectal Cancer Screening February 25, 2021American Cancer Society urges people to talk to their doctor about getting back to screening
- One-Third of Cancer Survivors Worried About Treatment and Healthcare Disruptions During the COVID-19 Pandemic February 24, 2021
- American Cancer Society Statement Regarding Senator Bob Dole's Lung Cancer Diagnosis February 19, 2021
- American Cancer Society Announces New Diversity in Cancer Research Program - Made Permanent By a $5 Million Grant from the Elizabeth and Phill Gross Family February 9, 2021The fund will create a permanent umbrella to develop initiatives to support researchers of color and increase diversity in cancer research and patient care
- American Cancer Society Launches Return to Screening Initiative with Support from Genentech February 25, 2021
Health Care Forum “War on Cancer” (March 30th 2017-Singapore)
Author Archives: czbiomed_t0k2xz
Collaboration with South Korea’s Largest Hospital to Develop New Cancer Treatment
Kocal Consulting Corporation Announces Collaboration with South Korea’s Largest Hospital to Develop New Cancer Treatment Well Marker Bio Co. Ltd., a biotech division of Asan Medical Center of South Korea, signs Memorandum of Understanding with CZ Biomed Corp. and Kocal … Continue reading
Posted in Uncategorized
Leave a comment
Partnerships with Bio-pharmaceutical Leaders
Kocal Consulting Corporation Celebrates new Consulting Agreement with CZ Biomed Corp to Help Deliver Real Value to Bio-pharmaceutical World Bio-pharmaceutical insiders have long known about the important, diverse work being done by CZ Biomed Corp, some of which could have … Continue reading
Posted in Cancer News, Colon Cancer, Prostate Cancer
Leave a comment
Oncolytic Virus Reduces Prostate Cancer
Oncolytic Virus Genetically Engineered from “Respiratory Syncytial Virus” (RSV) Reduces Prostate Cancer Tumors More Than 50% Press Release CZ BioMed Corp. Announces Successful Reduction of Prostate Cancer Tumors More Than 50% Using PRO-RVLYSIS(R) TAMPA, FL, August 26, 2013 – CZ … Continue reading
Posted in Prostate Cancer
Leave a comment
Oncolytic Virus Success Treating Colon Cancer
Oncolytic Virus “Respiratory Syncytial Virus” (RSV) Genetically Engineered to Treat Various Cancers Shows Stunning Results in Treating Colon Cancer Press Release – November 11, 2015 CZ BioMed Corp. Announces 2.5 Year Survival of Stage 4 Colon Cancer Patient. Cancer Free … Continue reading
Posted in Colon Cancer
Leave a comment
